Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
15.73
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Arcus Biosciences Announces New Employment Inducement Grants
October 11, 2022
From
Arcus Biosciences
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Arcus Biosciences Return On Capital Employed Insights
August 12, 2022
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
September 26, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 24, 2022
From
Arcus Biosciences
Via
Business Wire
Recap: Arcus Biosciences Q2 Earnings
August 03, 2022
Arcus Biosciences (NYSE:RCUS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
August 24, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer
August 08, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Analyst Ratings for Arcus Biosciences
August 04, 2022
Over the past 3 months, 4 analysts have published their opinion on Arcus Biosciences (NYSE:RCUS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
August 03, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Arcus Biosciences to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference
July 27, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 11, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 09, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
May 31, 2022
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 24, 2022
From
Arcus Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 11, 2022
Via
Benzinga
Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others
May 11, 2022
Roche isn't the only company working on an anti-TIGIT molecule.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 11, 2022
Via
Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 11, 2022
Good morning and welcome back for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
34 Stocks Moving in Wednesday's Pre-Market Session
May 11, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share.
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
May 10, 2022
From
Arcus Biosciences
Via
Business Wire
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Arcus Posts Encouraging Data For Domvanalimab-Based Regimes In Lung Cancer Settings
May 10, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.